A 60-day consumer study

Early Signal from a Real-World Study

A 60-day, at-home study of an anti-inflammatory supplement — tracked remotely, with blood work and standardized pain and fatigue questionnaires read side by side.

35

Participants dosed

60

Days remote monitoring

2

Independent readouts

Conducted by Reputable Health

Study Design

How We Tested It

A 60-day, at-home study pairing blood work with standardized pain and fatigue questionnaires — designed to find early signals and shape a larger, controlled trial.

01

Done at Home, 60 Days

Tracked entirely at home, so changes reflect everyday use rather than a lab setting.

02

Blood Draws at Start and End

Blood draws measuring C-reactive protein (CRP), a standard marker of inflammation in the body.

03

Standardized Questionnaires

Validated questionnaires for pain and fatigue, where a 3-point shift is the point at which people actually feel the difference.

04

Each Person as Their Own Baseline

Each person was compared to their own starting point. There was no placebo group, so these results show what changed — not proof of what caused it.

Cohort Enrollment Funnel

Screened73
Eligible56
Completed baseline survey52
Enrolled35
Took at least one dose33
Completed the study27

People took the supplement as directed 94.3% of the time — the drop-off was mostly about lab logistics, not people stopping the product.

Who Participated

A Compact Real-World Cohort

35

Started the supplement

27

Finished the study

26

Completed blood tests

60

Days of use

94.3%

Took it as directed

100%

Done at home

73 adults with chronic pain were screened; 35 started the supplement, 27 finished, and 26 completed both blood draws.

Full Breakdown

Comparative Summary Table

MetricChangeBaseline → EndInterpretation
Fatigue↓ 7.0 points55.7 → 48.7Improved
Pain interference↓ 4.8 points58.4 → 53.6Improved
Pain intensity↓ 0.73 pts2.73 → 2.00Improved
Inflammation marker (started high, 10 people)↓ 63%3.8 → 1.4 mg/LSmall group — needs more testing
Inflammation marker (started higher, 5 people)↓ 72%6.4 → 1.8 mg/LSmall group — needs more testing
Total sleepNo changeStable over 60 daysNo change
Resting heart rateNo changeStable over 60 daysNo change
Heart-rate variabilityNo changeStable over 60 daysNo change

This study had no placebo group. The numbers show what changed for participants — they don't prove what caused it.

Evidence

Example claims from real world use

Finding 01 / Fatigue

May Help Ease Fatigue

Fatigue improved from 55.7 to 48.7, with 70% of participants feeling meaningfully better by the standard 3-point threshold.

−7.0 pts

average fatigue change observed

70% of participants improved meaningfully

Finding 02 / Pain

May Help Reduce Pain

Pain interference and pain intensity both improved, with 53% of participants hitting the meaningful-change mark on pain interference.

−4.8 pts

average pain change observed

53% of participants improved meaningfully

Finding 03 / Biological Marker

May Support Lower Inflammation in Those Who Enter Inflamed

Among the 10 people who started inflamed, CRP fell from 3.8 to 1.4 mg/L. With so few people this is a promising hint — not proof — and what a larger trial should test.

−64 to −72%

average CRP change observed

10 participants entered measurably inflamed

Creative

Marketing assets designed from real world use claims

Ready-to-share creative built directly from the verified study data. Download individually or grab the full set.

May Help Reduce Pain Interference
May Help Reduce Pain InterferenceDownload
May Help Ease Fatigue
May Help Ease FatigueDownload
May Support Lower Inflammation
May Support Lower InflammationDownload